Skip to content

The functional prognosis of neurological disorder by bone metastasis with using MRI

The functional prognosis of neurological disorder by bone metastasis with using MRI - The functional prognosis of neurological disorder by bone metastasis with using MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000011842
Enrollment
50
Registered
2013-10-01
Start date
2013-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone metastasis

Interventions

None listed

Sponsors

Juntendo University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The target will de patients who have suffered from neuritis such as paralysis (lower than MMT 3) or/and bladder and rectum disturbance due to metastatic tumors of the spinal cord.

Exclusion criteria

Exclusion criteria: 1. The patient wishes to resign from the project. 2. The patient has been decided not to match the criteria after being registered to the project. 3. The symptoms of the neuritis has worsened and it is hard for the patient to continue participating. 4. Some harmful matter happened to the patient and it was hard for the patient to participate. 5. The project has been called off. 6. The doctor decided the patient should not participate in any case.

Design outcomes

Primary

MeasureTime frame
The percentage of the patient who recovered MMT (who measured more than 4) The patient will measure their MMTs after being treated for a year. We will examine if there is a significant difference between the two groups by using the Chi-square test.

Secondary

MeasureTime frame
The percentage of the patients who recoverd neuritis (bladder and rectum disturbance) The patient will self-assess the recovery of the neuritis after being treated for a year. We will examine if the is a significant difference between the two groups by using the Chi-square test.

Countries

Japan

Contacts

Public ContactTaito Asahina

Juntendo University Hospital radiation oncology

tasahina@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026